![Eric Fain](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eric Fain
Direktor/Vorstandsmitglied bei
ORCHESTRA BIOMED HOLDINGS, INC.
Vermögen: 358 582 $ am 31.05.2026
Profil
Eric S.
Fain is the founder of Aqua Heart, Inc. Current positions include President, Chief Executive Officer & Director at Procyrion, Inc. since 2018; Director at Orchestra BioMed, Inc. since 2018; and Lead Independent Non-Executive Director at Orchestra Biomed Holdings, Inc. since 2023.
Former roles include Director at CardioKinetix, Inc. and Avertix Medical, Inc.; Senior Vice President at Abbott Laboratories in 2017; President-Implantable Electronic Systems Division at St. Jude Medical LLC from 2012 to 2014; Vice President-Systems Development at Ventritex, Inc. from 1987 to 1997; Principal at Boston Scientific Corp.; and President at Cardiac Rhythm Management.
Education includes undergraduate studies at Brown University and a doctorate from Stanford University School of Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 14.05.2026 | 91.709 ( 0,17 % ) | 358 582 $ | 31.05.2026 |
Aktive Positionen von Eric Fain
| Unternehmen | Position | Beginn |
|---|---|---|
| ORCHESTRA BIOMED HOLDINGS, INC. | Direktor/Vorstandsmitglied | 26.01.2023 |
Procyrion, Inc.
 Procyrion, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices | Vorstandsvorsitzender | 30.07.2018 |
Orchestra BioMed, Inc.
 Orchestra BioMed, Inc. Medical SpecialtiesHealth Technology Develops transformative therapeutic products | Direktor/Vorstandsmitglied | 01.11.2018 |
Aqua Heart, Inc.
 Aqua Heart, Inc. Medical SpecialtiesHealth Technology Operates as a Med Tech company that develops cardiovascular treatment | Gründer | - |
Ehemalige bekannte Positionen von Eric Fain
| Unternehmen | Position | Ende |
|---|---|---|
| ABBOTT LABORATORIES | Corporate Officer/Principal | 01.07.2017 |
Ventritex, Inc.
 Ventritex, Inc. Medical SpecialtiesHealth Technology Designs, develops and sells cadence implantable defibrilators | Corporate Officer/Principal | - |
| BOSTON SCIENTIFIC CORPORATION | Corporate Officer/Principal | - |
Avertix Medical Systems, Inc.
 Avertix Medical Systems, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets cardiac medical devices | Direktor/Vorstandsmitglied | - |
Cardiac Rhythm Management
 Cardiac Rhythm Management Medical SpecialtiesHealth Technology Manufactures implantable devices to treat arrhythmias | Präsident | - |
Ausbildung von Eric Fain
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
14
Beziehungen ersten Grades
13
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 13 |
|---|---|
Abbott Laboratories
 Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
St. Jude Medical LLC
 St. Jude Medical LLC Medical SpecialtiesHealth Technology Develops, manufactures and distributes cardiovascular medical devices | Health Technology |
Ventritex, Inc.
Ventritex, Inc. Medical SpecialtiesHealth Technology Designs, develops and sells cadence implantable defibrilators | Health Technology |
Boston Scientific Corp.
 Boston Scientific Corp. Medical SpecialtiesHealth Technology Develops, manufactures and markets cardiology, endoscopy, peripheral intervention, urology & neuromodulation equipment | Health Technology |
Procyrion, Inc.
Procyrion, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices | Health Technology |
Brown University
 Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cardiac Rhythm Management
Cardiac Rhythm Management Medical SpecialtiesHealth Technology Manufactures implantable devices to treat arrhythmias | Health Technology |
CardioKinetix, Inc.
 CardioKinetix, Inc. Medical SpecialtiesHealth Technology Develops ventricular partitioning device for heart failure disease | Health Technology |
Avertix Medical Systems, Inc.
Avertix Medical Systems, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets cardiac medical devices | Health Technology |
Stanford University School of Medicine
 Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Orchestra BioMed, Inc.
Orchestra BioMed, Inc. Medical SpecialtiesHealth Technology Develops transformative therapeutic products | Health Technology |
Aqua Heart, Inc.
Aqua Heart, Inc. Medical SpecialtiesHealth Technology Operates as a Med Tech company that develops cardiovascular treatment | Health Technology |
Orchestra Biomed Holdings, Inc.
 Orchestra Biomed Holdings, Inc. Medical SpecialtiesHealth Technology Manufactures therapeutic devices and solutions for treatment of hypertension in cardiac patients | Health Technology |
